A double-blind, randomised, controlled, multi-centre safety study of a refrigerator-stable formulation of VARIVAX in healthy 12 to 15 month-old infants.
Phase of Trial: Phase IV
Latest Information Update: 16 Mar 2017
At a glance
- Drugs Varicella zoster virus vaccine live (Primary) ; Measles mumps and rubella virus vaccine
- Indications Varicella zoster virus infections
- Focus Adverse reactions
- Sponsors sanofi pasteur MSD
- 08 Apr 2009 Additional trial investigator Fiquet A added as reported by ClinicalTrials.gov.
- 10 Mar 2007 New trial record.